Performance of degradable composite bone repair products made via three-dimensional fabrication techniques

被引:189
作者
Roy, TD
Simon, JL
Ricci, JL
Rekow, ED
Thompson, VP
Parsons, JR
机构
[1] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Orthopaed, Newark, NJ 07103 USA
[2] Rutgers State Univ, Dept Biomed Engn, Piscataway, NJ 08854 USA
[3] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Prosthodont & Biomat, Newark, NJ 07103 USA
[4] NYU, Coll Dent, Dept Basic Sci & Craniofacial Biol & Orthodont, New York, NY 10010 USA
[5] NYU, Coll Dent, Dept Biomat & Biomimet, New York, NY 10010 USA
来源
JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A | 2003年 / 66A卷 / 02期
关键词
bone graft; tissue engineering; PLGA; scaffold fabrication; solid freeform fabrication;
D O I
10.1002/jbm.a.10582
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
This study analyzed the in vivo performance of composite degradable bone repair products fabricated using the TheriForm(TM) process, a solid freeform fabrication (SFF) technique, in a rabbit calvarial defect model at 8 weeks. Scaffolds were composed of polylactic-co-glycolic acid (PLGA) polymer with 20% w/w beta-tricalcium phosphate (beta-TCP) ceramic with engineered macroscopic channels, a controlled porosity gradient, and a controlled pore size for promotion of new bone ingrowth. Scaffolds with engineered macroscopic channels and a porosity gradient had higher percentages of new bone area compared to scaffolds without engineered channels. These scaffolds also had higher percentages of new bone area compared to unfilled control defects, suggesting that scaffold material and design combinations could be tailored to facilitate filling of bony defects. This proof-of-concept study demonstrated that channel size, porosity, and pore size can be controlled and used to influence new bone formation and calvarial defect healing. (C) 2003 Wiley Periodicals, Inc.
引用
收藏
页码:283 / 291
页数:9
相关论文
共 41 条
[1]  
Agrawal CM, 2001, J BIOMED MATER RES, V55, P141, DOI 10.1002/1097-4636(200105)55:2<141::AID-JBM1000>3.0.CO
[2]  
2-J
[3]   Orthopaedic applications for PLA-PGA biodegradable polymers [J].
Athanasiou, KA ;
Agrawal, CM ;
Barber, FA ;
Burkhart, SS .
ARTHROSCOPY-THE JOURNAL OF ARTHROSCOPIC AND RELATED SURGERY, 1998, 14 (07) :726-737
[4]  
Behravesh E, 1999, CLIN ORTHOP RELAT R, pS118
[5]   Mechanical and in vivo performance of hydroxyapatite implants with controlled architectures [J].
Chu, TMG ;
Orton, DG ;
Hollister, SJ ;
Feinberg, SE ;
Halloran, JW .
BIOMATERIALS, 2002, 23 (05) :1283-1293
[6]   GEL CASTING OF RESORBABLE POLYMERS .2. INVITRO DEGRADATION OF BONE-GRAFT SUBSTITUTES [J].
COOMBES, AGA ;
HECKMAN, JD .
BIOMATERIALS, 1992, 13 (05) :297-307
[7]   GEL CASTING OF RESORBABLE POLYMERS .1. PROCESSING AND APPLICATIONS [J].
COOMBES, AGA ;
HECKMAN, JD .
BIOMATERIALS, 1992, 13 (04) :217-224
[8]   The future of biodegradable osteosyntheses [J].
Cordewener, FW ;
Schmitz, JP .
TISSUE ENGINEERING, 2000, 6 (04) :413-424
[9]  
Curodeau A, 2000, J BIOMED MATER RES, V53, P525, DOI 10.1002/1097-4636(200009)53:5<525::AID-JBM12>3.0.CO
[10]  
2-1